rs2304016

A SNP in the SCN2A gene on chromosome 2. Its most notable genotype is A;A: common in complete genomics

Gene
SCN2A
Location
Chr 2165,311,993 (GRCh38)
Highest magnitude
0.0Typical
Tested on
23andMe
Minor allele frequency
3%

Genotypes

As shown in 23andMe and AncestryDNA files.

  1. A;AMost notableGoodcommon in complete genomicsTypical · 0.092% of people

On SNPedia: (A;A). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.

Frequency

Share of each genotype in 7 HapMap populations.

  • AverageA;A 92%
  • European ancestry (Utah)A;A 97%
  • Han Chinese (Beijing)A;A 69%
  • Japanese (Tokyo)A;A 82%
  • Yoruba (Nigeria)A;A 99%
  • African ancestry (Southwest US)A;A 98%
  • Gujarati IndianA;A 99%
  • Luhya (Kenya)A;A 97%

Notes

From SNPedia

Notes

rs2304016 (IVS7-32A>G) is a SNP within the SCN2A (sodium channel, voltage-gated, type II, alpha subunit). among 471 Chinese epilepsy patients (of which 272 were drug responsive and 199 drug resistant), A-allele carriers associated with resistance to anti-epileptic drugs (OR 2.1, 95% CI 1.2-3.7, p=0.007), haplotypes containing A-alleles were also associated w/ drug resistance

Source and license

Adapted from rs2304016 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.

SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.